Andreas Rummelt

Andreas Rummelt

Chief Executive Officer at
Interpharmalink

Net worth: 5 M $ as of 2026-05-30

69 year
Health Technology
Health Services
Producer Manufacturing

Profile

Andreas Rummelt currently works at InterPharmaLink AG, as Chief Executive Officer & Partner from 2011, Selica Ltd., as Director, Cypralis Ltd., as Non-Executive Director, Alvogen Emerging Markets Holdings Ltd., as Independent Director, and LEUKOCARE AG, as Member-Supervisory Board from 2016.
Dr. Rummelt also formerly worked at Novartis Pharmaceuticals UK Ltd., as CEO & Head-Technical Operations from 1985 to 2008, Sandoz Pharmaceuticals AG, as Chief Executive Officer in 2008, Acino International AG, as Vice Chairman in 2013, Alexion Pharmaceuticals, Inc., as Independent Director from 2011 to 2021, Eon Labs, Inc., as Director, Habasit AG, as Director, Famar SA, as Director, Mipharm SpA, as Director, Xellia Pharmaceuticals ApS, as Director, AstraZeneca PLC, as Non-Executive Director from 2021 to 2025, Novartis International AG, as Group Head-Quality Assurance in 2010, and Novartis AG, as Head-Quality Assurance & Technical Operations from 2006 to 2010.
Dr. Rummelt received his doctorate degree in 1983 from Friedrich-Alexander University of Erlangen-Nuremberg.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-30 27,205 ( 0% ) 5 M $ 2026-05-30

Andreas Rummelt active positions

CompaniesPositionStart
Director/Board Member -
Interpharmalink
Chief Executive Officer 2010-12-31
Director/Board Member -
Director/Board Member 2016-07-14
Director/Board Member -

Former positions of Andreas Rummelt

CompaniesPositionEnd
ASTRAZENECA PLC Director/Board Member 2025-04-10
ALEXION PHARMACEUTICALS, INC. Director/Board Member 2021-07-13
ACINO HOLDING AG Director/Board Member 2013-12-16
NOVARTIS AG Corporate Officer/Principal 2009-12-31
░░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Andreas Rummelt's experience

Training of Andreas Rummelt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Producer Manufacturing

Health Technology

Consumer Services

Health Technology

Health Technology

Health Services

Health Services

Interpharmalink

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Andreas Rummelt
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!